header
Image from OpenLibrary

Biochemical studies for evaluating the impact of hepatitis C virus co-infection with schistosomiasis on liver fibrosis progression using biotechnology / Mohamed Salah Abdelkader Albannan ; Supervised Sanaa Osman Abdallah , Abdelfattah Mohamed Attallah

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Mohamed Salah Abdelkader Albannan , 2017Description: 114 P. : maps , charts , facsimiles ; 25cmOther title:
  • درا{uئإآ٣}{uئإ٨إ}ت {uئإؤآ}{uئآئئ}{uئإإ٤}{uئآئئ}{uئإ٨إ}{uئإ٨آ}{uئآئئ}{uئإ٩٤} {uئإء٣}{uئآئئ}{uئإإإ}{uئآئإ}{uئإ٩٤} {uئإؤئ}{uئإ٩٨}{uئإؤ٨}{uئآئئ}{uئآئئ}{uئإإ٢} {uئإ٩٧}{uئإ٨٤}{uئإ٩آ}{uئآئئ}{uئإءإ} {uئإإ٣}{uئإءإ}ا{uئإؤ٣}{uئإؤ٨}{uئإ٩٤} ا{uئإئ٩}{uئإؤئ}{uئإ٩٨}{uئآءؤ}{uئإ٨إ}ب ا{uئإؤئ}{uئإؤأ}{uئإ٩٢}{uئإءء}ى ا{uئإؤئ}{uئإؤ٤}{uئآئئ}{uئإءإ}و{uئإآ٣}{uئإئ٢} {uئإآ٣}{uئإئ٢} {uئإإ٣}{uئإأء} ا{uئإؤئ}{uئإ٩٢}{uئإإ٠}{uئآءؤ}{uئإ٨إ}ر{uئإآ٣}{uئآئئ}{uئإ٨إ} {uئإأآ}{uئإإ٠}{uئإئ٠} {uئإ٩٧}{uئإأ٤}{uئإإإ}ر ا{uئإؤئ}{uئإ٩٨}{uئإإ٠}{uئآئئ}{uئإؤ٢} ا{uئإؤئ}{uئإؤأ}{uئإ٩٢}{uئإءء}ي {uئإ٩١}{uئإ٨إ}{uئإآ٣}{uئإ٩٨}{uئإء٨}{uئإءء}ام ا{uئإؤئ}{uئإ٩٨}{uئإؤأ}{uئإإ٨}{uئإإإ}{uئإؤئ}{uئإإإ}{uئإ٩ئ}{uئآئئ}{uئإ٨إ} ا{uئإؤئ}{uئإء٤}{uئآئئ}{uئإإإ}{uئآئإ}{uئإ٩٤} [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (Ph.D.) - Cairo University - Faculty of Science - Department of Biochemistry Summary: This study aimed to investigate the influence of hepatitis C virus (HCV)/ Schistosoma mansoni (S. mansoni) co-infection on the concentration of hepatitis C viral nonstructural protein-4 (NS4) in addition to collagen III and matrixmetalloproteinase-1 (MMP-1) in different hepatic fibrosis stages. We found that co-infected patients (n=186) showed significantly (P <0.05, Mann{u2013} Whitney U-test) higher concentrations of HCV-NS4, collagen III and collagen III/MMP-1 ratio (CMR) than those with HCV mono-infection (n=104) in different fibrosis-stages. Conversely, co-infected patients showed significantly lower concentrations of MMP-1 when compared to HCV mono-infection. The elevated levels of CMR in case of HCV mono-infection yielded an estimated odds ratio of 1.8 and 2.6 for developing significant fibrosis (F2-F4) and cirrhosis (F4), respectively. Surprisingly, HCV/S. mansoni co-infection increased the risk for developing F2-F4 and F4 several folds yielding an estimated odds ratio of 11.1 and 5.2, respectively. Thus, elevated levels of HCV-NS4 and CMR in HCV/S. mansoni co infection suggest increased susceptibility of co-infected patients, compared to those with HCV mono-infection, for accelerating hepatic fibrosis progression
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.12.02.Ph.D.2017.Mo.B (Browse shelf(Opens below)) Not for loan 01010110074352000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.12.02.Ph.D.2017.Mo.B (Browse shelf(Opens below)) 74352.CD Not for loan 01020110074352000

Thesis (Ph.D.) - Cairo University - Faculty of Science - Department of Biochemistry

This study aimed to investigate the influence of hepatitis C virus (HCV)/ Schistosoma mansoni (S. mansoni) co-infection on the concentration of hepatitis C viral nonstructural protein-4 (NS4) in addition to collagen III and matrixmetalloproteinase-1 (MMP-1) in different hepatic fibrosis stages. We found that co-infected patients (n=186) showed significantly (P <0.05, Mann{u2013} Whitney U-test) higher concentrations of HCV-NS4, collagen III and collagen III/MMP-1 ratio (CMR) than those with HCV mono-infection (n=104) in different fibrosis-stages. Conversely, co-infected patients showed significantly lower concentrations of MMP-1 when compared to HCV mono-infection. The elevated levels of CMR in case of HCV mono-infection yielded an estimated odds ratio of 1.8 and 2.6 for developing significant fibrosis (F2-F4) and cirrhosis (F4), respectively. Surprisingly, HCV/S. mansoni co-infection increased the risk for developing F2-F4 and F4 several folds yielding an estimated odds ratio of 11.1 and 5.2, respectively. Thus, elevated levels of HCV-NS4 and CMR in HCV/S. mansoni co infection suggest increased susceptibility of co-infected patients, compared to those with HCV mono-infection, for accelerating hepatic fibrosis progression

Issued also as CD

There are no comments on this title.

to post a comment.